Cannabis constituent has no effect on MS progression, study shows

But there may be some benefit to those at the lower end of the disability scale

2013-07-23

(Press-News.org) The first large non-commercial clinical study to investigate whether the main active constituent of cannabis (tetrahydrocannabinol or THC) is effective in slowing the course of progressive multiple sclerosis (MS), shows that there is no evidence to suggest this; although benefits were noted for those at the lower end of the disability scale.

The study is published in The Lancet Neurology.

The CUPID (Cannabinoid Use in Progressive Inflammatory brain Disease) study was carried out by researchers from Plymouth University Peninsula Schools of Medicine and Dentistry. The study was funded by the Medical Research Council (MRC), the Multiple Sclerosis Society and the Multiple Sclerosis Trust, and managed by the National Institute for Health Research (NIHR) on behalf of the MRC-NIHR partnership.

CUPID enrolled nearly 500 people with MS from 27 centres around the UK, and has taken eight years to complete. People with progressive MS were randomised to receive either THC capsules or identical placebo capsules for three years, and were carefully followed to see how their MS changed over this period. The two main outcomes of the trial were a disability scale administered by neurologists (the Expanded Disability Status Scale), and a patient report scale of the impact of MS on people with the condition (the Multiple Sclerosis Impact Scale 29).

Overall the study found no evidence to support an effect of THC on MS progression in either of the main outcomes. However, there was some evidence to suggest a beneficial effect in participants who were at the lower end of the disability scale at the time of enrolment but, as the benefit was only found in a small group of people rather than the whole population, further studies will be needed to assess the robustness of this finding.

One of the other findings of the trial was that MS in the study population as a whole progressed slowly, more slowly than expected. This makes it more challenging to find a treatment effect when the aim of the treatment is to slow progression.

As well as evaluating the potential neuroprotective effects and safety of THC over the long-term, one of the aims of the CUPID study was to improve the way that clinical trial research is done, by exploring newer methods of measuring MS and using the latest statistical methods to make the most of every piece of information collected. This analysis continued for several months and has provided important information about conducting further large scale clinical trials in MS.

Professor John Zajicek, Professor of Clinical Neuroscience at Plymouth University Peninsula Schools of Medicine and Dentistry, said: "To put this study into context: current treatments for MS are limited, either being targeted at the immune system in the early stages of the disease or aimed at easing specific symptoms such as muscle spasms, fatigue or bladder problems. At present there is no treatment available to slow MS when it becomes progressive. Progression of MS is thought to be due to death of nerve cells, and researchers around the world are desperately searching for treatments that may be 'neuroprotective'. Laboratory experiments have suggested that certain cannabis derivatives may be neuroprotective."

He added: "Overall our research has not supported laboratory based findings and shown that, although there is a suggestion of benefit to those at the lower end of the disability scale when they joined CUPID, there is little evidence to suggest that THC has a long term impact on the slowing of progressive MS."

###

ELSE PRESS RELEASES FROM THIS DATE:

A new player in brain disease and stroke

2013-07-23

In degenerative brain diseases and after stroke, nerve cells die while their support cells activate the brain's immune system to cause further damage. Now Jonathan Gilthorpe, Adrian Pini and Andrew Lumsden at the MRC Centre for Developmental Neurobiology at King's College London, have found that a single protein, histone H1, causes these distinct outcomes. The research passed peer review within a week of being published in F1000Research, where Jan-Marino Ramirez, of the University of Washington, called the work "a very important contribution to our understanding of neurodegenerative ...

6 months of computing time generates detailed portrait of cloth behavior

2013-07-23

PITTSBURGH—It would be impossible to compute all of the ways a piece of cloth might shift, fold and drape over a moving human figure. But after six months of computation, researchers at Carnegie Mellon University and the University of California, Berkeley, are pretty sure they've simulated almost every important configuration of that cloth. "I believe our approach generates the most beautiful and realistic cloth of any real-time technique," said Adrien Treuille, associate professor of computer science and robotics at Carnegie Mellon. To create this cloth database, ...

Controlling genes with light

2013-07-23

CAMBRIDGE, MA -- Although human cells have an estimated 20,000 genes, only a fraction of those are turned on at any given time, depending on the cell's needs — which can change by the minute or hour. To find out what those genes are doing, researchers need tools that can manipulate their status on similarly short timescales. That is now possible, thanks to a new technology developed at MIT and the Broad Institute that can rapidly start or halt the expression of any gene of interest simply by shining light on the cells. The work is based on a technique known as optogenetics, ...

Team led by University of Leicester sets new record for cosmic X-ray sightings

2013-07-23

Scientists led by the University of Leicester have set a new record for cosmic X-ray sources ever sighted – creating an unprecedented cosmic X-ray catalogue that will provide a valuable resource allowing astronomers to explore the extreme Universe. The XMM-Newton Survey Science Centre, led by a team from the University of Leicester's Department of Physics and Astronomy, used the University's 'ALICE' supercomputer to help them produce a new X-ray catalogue, dubbed "3XMM". This new catalogue contains over half a million X-ray source detections, representing a 50% increase ...

Brain picks out salient sounds from background noise by tracking frequency and time, study finds

2013-07-23

New research reveals how our brains are able to pick out important sounds from the noisy world around us. The findings, published online today in the journal eLife, could lead to new diagnostic tests for hearing disorders. Our ears can effortlessly pick out the sounds we need to hear from a noisy environment, for example hearing our mobile phone ring tone in the middle of the Notting Hill Carnival, but how our brains process this information -- the so-called 'cocktail party problem' -- has been a longstanding research question in hearing science. Researchers have previously ...

Between B cells and T cells

2013-07-23

Mature cells develop through a number of immature stages. During this process, they must remember the specialization they are committed to. For immune system B cells, Rudolf Grosschedl of the Max Planck Institute of Immunobiology and Epigenetics and his team have discovered that the transcription factor EBF1 is crucial for B cells to remember who they are. When the researchers switched off the transcription factor, the cells lost their previous identity and developed into T cells. Unlike most other cell types, B cells have a characteristic footprint in their genetic makeup ...

Researchers develop new approach for studying deadly brain cancer

2013-07-23

CHAMPAIGN, Ill. — Human glioblastoma multiforme, one of the most common, aggressive and deadly forms of brain cancer, is notoriously difficult to study. Scientists have traditionally studied cancer cells in petri dishes, which have none of the properties of the brain tissues in which these cancers grow, or in expensive animal models. Now a team of engineers has developed a three-dimensional hydrogel that more closely mimics conditions in the brain. In a paper in the journal Biomaterials, the researchers describe the new material and their approach, which allows them to ...

Study: No link between mercury exposure and autism-like behaviors

2013-07-23

The potential impact of exposure to low levels of mercury on the developing brain – specifically by women consuming fish during pregnancy – has long been the source of concern and some have argued that the chemical may be responsible for behavioral disorders such as autism. However, a new study that draws upon more than 30 years of research in the Republic of Seychelles reports that there is no association between pre-natal mercury exposure and autism-like behaviors. "This study shows no evidence of a correlation between low level mercury exposure and autism spectrum-like ...

Populations of grassland butterflies decline almost 50 percent over 2 decades

2013-07-23

This news release is available in German. Copenhagen -- Grassland butterflies have declined dramatically between 1990 and 2011. This has been caused by intensifying agriculture and a failure to properly manage grassland ecosystems, according to a report from the European Environment Agency (EEA). In the report the data of the Butterfly monitoring scheme in Germany have been incorporated, which is scientifically supported by the Helmholtz Centre for Environmental Research (UFZ). UFZ scientists have also contributed to the analysis of population trends. The fall in ...

Keeping centrioles in check to ensure proper cell division

2013-07-23

This news release is available in German. The duplication of cellular contents and their distribution to two daughter cells during cell division are amongst the most fundamental features of all life on earth. How cell division occurs and is coordinated with organismal development is a subject of intense research interest, as is how this process malfunctions in the development of tumors. Alex Dammermann and his team from the Max F. Perutz Laboratories (MFPL) of the University of Vienna and the Medical University of Vienna, together with his collaborators from the Institute ...

Medicaid extension policies that cover all immigrants in a post-COVID world reduce inequities in postpartum insurance coverage

Computing leaders propose measures to combat tech-facilitated intimate partner violence, human trafficking, and child exploitation

Sometimes, when competitors collaborate, everybody wins

EU Flagship project DORIAN GRAY to use pioneering AI and avatar technology to uncover links between cardiovascular disease (CVD) and mild cognitive impairment (MCI) to improve healthy ageing and survi

Cannabis constituent has no effect on MS progression, study shows

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: